Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Eledon Pharmaceuticals, Inc. ELDN
$2.46
-$0.28 (-11.19%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
37831200.00000000
-
week52high
3.95
-
week52low
1.68
-
Revenue
0
-
P/E TTM
0
-
Beta
2.11626200
-
EPS
-6.35000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Outperform | Outperform | 01 июн 2022 г. |
| HC Wainwright & Co. | Buy | Buy | 24 ноя 2021 г. |
| SVB Leerink | Outperform | Outperform | 27 апр 2021 г. |
| Cantor Fitzgerald | Overweight | 23 мар 2021 г. | |
| SVB Leerink | Outperform | 08 февр 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Perrin Steven | A | 155000 | 155000 | 01 февр 2023 г. |
| Ogier Walter C | A | 20000 | 20000 | 01 февр 2023 г. |
| Katkin Keith | A | 20000 | 20000 | 01 февр 2023 г. |
| Lee June | A | 20000 | 20000 | 01 февр 2023 г. |
| LYONS GARY A | A | 20000 | 20000 | 01 февр 2023 г. |
| McBride John S. | A | 20000 | 20000 | 01 февр 2023 г. |
| Gros David-Alexandre C | A | 153600 | 153600 | 01 февр 2023 г. |
| Gros David-Alexandre C | A | 300000 | 300000 | 01 февр 2023 г. |
| Hillson Jan | A | 20000 | 20000 | 01 февр 2023 г. |
| Little Paul Sean | A | 155000 | 155000 | 01 февр 2023 г. |
Новостная лента
Eledon Pharmaceuticals, Inc. (ELDN) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 20:35
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN ) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Paul Little – Chief Financial Officer David-Alexandre Gros – Chief Executive Officer Steve Perrin – President and Chief Scientific Officer Jeff Bornstein – Chief Medical Officer Conference Call Participants Pete Stavropoulos – Cantor Fitzgerald Matt Kaplan – Ladenburg Thalmann Thomas Smith – SVB Securities Rami Katkhuda – LifeSci Capital Operator Good day and welcome to the Eledon Pharmaceuticals Third Quarter 2022 Financial Results Conference Call. All participants will be in a listen-only mode.
Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference
GlobeNewsWire
22 сент 2022 г. в 16:05
IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29, 2022 at 2:00 p.m. ET in New York City.
Eledon Pharmaceuticals to Participate in Two Upcoming Investor Conferences
GlobeNewsWire
29 авг 2022 г. в 08:00
IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that senior management will participate in two upcoming investor conferences:
Eledon Pharmaceuticals, Inc. (ELDN) CEO David-Alexandre Gros on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
11 авг 2022 г. в 21:33
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Paul Little - CFO David-Alexandre Gros - CEO Steve Perrin - President and Chief Scientific Officer Jeff Bornstein - Chief Medical Officer Conference Call Participants Thomas Smith - SVB Securities Rami Katkhuda - LifeSci Capital Operator Greetings, and welcome to Eledon Pharmaceuticals Second Quarter Financial Results Conference Call. At this time all participants are in a listen-only mode.
Penny Stocks To Buy Now? 3 To Watch This Week
PennyStocks
31 мая 2022 г. в 09:49
Penny stocks to watch this week. The post Penny Stocks To Buy Now?